Summary
Introduction
Lactobacilli, especially Lactobacillus (L.) rhamnosus, are common and well-documented components of commercial probiotics [1]. Whole genome sequencing (WGS) is often used to compare bacterial genomes and their relatedness. In outbreak situations, it is used to investigate the transmission of pathogenic bacteria. WGS has also been used to determine safety in probiotics, by looking at potential virulence factors and resistance genes.
Case presentation
This case report describes a 56-year old multi-traumatised, immunocompetent woman who was given L. rhamnosus GG as a probiotic, and later developed a blood stream infection with L. rhamnosus GG.
The patient was fed by a nasogastric tube, and she also had a central venous catheter for parenteral feeding. When the patient developed diarrhoea after long-term hospitalisation, she was given L. rhamnosus GG, as a probiotic, which was standard care on the ward where she was hospitalised. In this case report we describe the use of WGS to demonstrate that a patient fed with L. rhamnosus GG as a probiotic, developed a blood stream infection with the same strain.
Conclusion
In this case WGS was applied to show the relatedness of a probiotic and a pathogenic strain of L. rhamnosus GG. This case emphasises the need for caution when administering probiotics to patients with indwelling catheters. The patient was immunocompetent and she cleared the infection without the need for antibiotics.
Background
Lactobacilli are some of the most well-documented and used probiotics [1,2]. Probiotics are “live microorganisms, that when administered in adequate amounts, confer a health benefit on the host” [3]. The use of probiotics is widespread and from a survey undertaken by the National Health Interview Service, 1.6% of the adult US population had ingested pro- or prebiotics within the last 30 days [4]. Probiotics are commonly used as prevention of antibiotic induced diarrhoea [5]. There is also evidence suggesting their potential antimicrobial effects against bacterial pathogens of the gastrointestinal tract as well as some viruses, such as rotavirus [6].
Case
This case describes a 56-year old woman hospitalised for specialised neurorehabilitation after having been involved in a traffic accident, where she became multi-traumatised with severe intra-abdominal injuries as well as widespread, hypoxic cerebral injury. Clinically the patient presented with left-sided, spastic hemiparesis, aphasia, truncal instability as well as diarrhoea, nausea, vomiting and periodic weight loss. Sufficient nutrition could not be attained with a nasogastric tube, and parenteral nutrition via a central venous catheter was initiated.
During the admission, the patient became febrile, without features of sepsis. Antibiotic treatment was therefore not initiated, but blood cultures were performed. Three of four blood cultures from the central venous catheter showed growth of L. rhamnosus. The central venous catheter was removed, and the tip was cultured but was negative. In the days leading up to the febrile episode the patient had received probiotics in the form of a capsule (commercially available, proprietary probiotic containing L. rhamnosus), where the capsule was opened and the content mixed with water, and fed to the patient via a nasogastric tube. Probiotics were routinely used on the ward as a standard treatment for patients with diarrhoea.
As the patient remained clinically stable and with no increase in infectious parameters, antibiotics were not initiated. The probiotics were discontinued. The infectious parameters were checked daily and remained low. Control blood cultures on day two and five came back negative, and the patient had thus cleared the L. rhamnosus bacteraemia without need for antimicrobial therapy.
To examine whether the isolate of L. rhamnosus from the patient's blood came from the ingested probiotics, WGS was performed on the Illumina MiSeq platform (Illumina Inc., San Diego, USA), producing 150 bp paired-reads as previously described [7]. The sequencing reads generated were compared to a publicly available sequence of L. rhamnosus GG from the probiotic manufacturer (NCBI Sequence Read Archive run no. SRR8313513) [8] and full-length L. rhamnosus genomes downloaded from NCBI GenBank. This was done using NASP (Northern Arizona SNP Pipeline) [9], a pipeline for comparison of genomic data and identification of single nucleotide polymorphisms (SNPs) between genomes, with L. rhamnosus GG whole genome sequence, strain GG (ATCC 53103) (Genbank accession no. NC_013198.1) as reference. From the results of NASP, SNP distances were calculated using the program snp-dist [10] and a phylogenetic tree was built with fasttree v. 2.1.11 [11] using FastTreeDbl (double precision) to obtain correct branch length estimations for very similar sequences. Our analysis identified 0 SNPs between L. rhamnosus isolated from the blood and L. rhamnosus GG from the probiotic capsule (DSM 33156), and close clustering of these and other L. rhamnosus GG genomes in the phylogenetic tree (Figure 1 and Supplementary table 1). A maximum of 13 SNPs was identified between the L. rhamnosus genomes shown in the subtree highlighted in the top left corner of the figure. Based on these analyses, results indicate that the L. rhamnosus isolate from the blood of the patient originated from the L. rhamnosus GG in the probiotic from the capsule.
Figure 1.
Phylogenetic tree showing the relatedness between L. rhamnosus genomes publicly available at NCBI GenBank, and L. rhamnosus GG from the blood of the patient as well as L. rhamnosus GG from the probiotic manufacturer (L. rhamnosus GG (DSM 33156)). The tree on the right includes all available L. rhamnosus genomes, while the subtree at the top left only includes genome closely related to L. rhamnosus GG from the blood of the patient and the probiotic capsule. SNP: Single nucleotide polymorphisms.
Discussion
Lactobacilli are low-virulent bacteria, seldomly giving rise to invasive clinical infections and they are often used as probiotics to treat diarrhoea after a long-term antibiotic treatment [5].
This case report sheds light on the need to use caution when using probiotics for patients with indwelling intravascular catheters. The patient described in this case was healthy apart from her trauma, and was therefore immunocompetent, which may explain why her bacteraemia cleared rapidly and without the need for antibiotics. The probiotic could have entered the blood through the central venous catheter, seen in the light of its proximity to the nasogastric tube or possibly through bacterial translocation from the intestine. The patient was not known to suffer from any intestinal bowel diseases that could have disrupted the intestinal mucosa, however, she had diarrhoea, and had suffered intraabdominal injuries, so this is still a possibility.
L. rhamnosus can give rise to clinically invasive infections among immunocompromised patients. It has been described in a range of infections, such as abscesses, endocarditis and bacteraemia [12]. Bacteraemia with L. rhamnosus is furthermore described in patients with central venous catheters on Intensive Care Units. This is why experts recommend thorough hand hygiene after handling these catheters by healthcare workers, who have previously handled probiotic formulations [13]. L. rhamnosus bacteraemia is also described among immunocompetent patients with ischemic colitis and ulcerative colitis, where a possible bacterial translocation, due to disruption of the intestinal mucosa, has taken place [14]. In this case, we describe an immunologically healthy patient who had been multi-traumatised and therefore was clearly compromised as well as having diarrhoea which could facilitate translocation. Probiotics should therefore also be handled with care in patients suffering from intraabdominal trauma.
In conclusion, this is the first case using WGS to show that the exact same strain that was used as a probiotic in a patient, gave rise to a subsequent blood stream infection.
Ethical declaration
Written informed consent has been given and retained by authors.
Conflict of interest statement
The authors declare no conflict of interests.
Funding
The study was supported by internal funding.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.infpip.2022.100200.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Gorbach S.L., Newton S.I. The Discovery of Lactobacillus GG. Nutr Today. 1996;31(Supplement 1):5S. doi: 10.1097/00017285-199611001-00002. [DOI] [Google Scholar]
- 2.Gorbach S., Doron S., Magro F. The microbiota in gastrointestinal pathophysiology: implications for human health, prebiotics, probiotics, and dysbiosis. 2017. Lactobacillus rhamnosus GG; pp. 79–88. [DOI] [Google Scholar]
- 3.Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton C., Swanson K.S., Cani P.D., Verbeke K., Reid G. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491–502. doi: 10.1038/nrgastro.2017.75. Epub 2017 Jun 14. PMID: 28611480. [DOI] [PubMed] [Google Scholar]
- 4.Clarke T.C., Black L.I., Stussman B.J., Barnes P.M., Nahin R.L. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report. 2015;(79) [PMC free article] [PubMed] [Google Scholar]
- 5.Agamennone V., Krul C.A.M., Rijkers G., Kort R. A practical guide for probiotics applied to the case of antibiotic-associated diarrhoea in The Netherlands. BMC Gastroenterol. 2018;18(1) doi: 10.1186/s12876-018-0831-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Liévin-Le Moal V., Servin A.L. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: From probiotics to gastrointestinal anti- infectious biotherapeutic agents. Clin Microbiol Rev. 2014;27(2) doi: 10.1128/CMR.00080-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pinholt M., Larner-Svensson H., Littauer P., Moser C.E., Pedersen M., Lemming L.E., Ejlertsen T., Søndergaard T.S., Holzknecht B.J., Justesen U.S., Dzajic E., Olsen S.S., Nielsen J.B., Worning P., Hammerum A.M., Westh H., Jakobsen L. Multiple hospital outbreaks of vanA Enterococcus faecium in Denmark, 2012-13, investigated by WGS, MLST and PFGE. J Antimicrob Chemother. 2015 Sep;70(9):2474–2482. doi: 10.1093/jac/dkv142. Epub 2015 Jun 1. PMID: 26031466. [DOI] [PubMed] [Google Scholar]
- 8.Stage M., Wichmann A., Jørgensen M., Vera-Jimenéz N.I., Wielje M., Nielsen D.S., Sandelin A., Chen Y., Baker A. Lactobacillus rhamnosus GG Genomic and phenotypic stability in an industrial production process. Appl Environ Microbiol. 2020 Mar 2;86(6):e02780-19. doi: 10.1128/AEM.02780-19. PMID: 31924618; PMCID: PMC7054085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sahl J.W., Lemmer D., Travis J., Schupp J.M., Gillece J.D., Aziz M., Driebe E.M., Drees K.P., Hicks N.D., Williamson C.H.D., Hepp C.M., Smith D.E., Roe C., Engelthaler D.M., Wagner D.M., Keim P. NASP: an accurate, rapid method for the identification of SNPs in WGS datasets that supports flexible input and output formats. Microb Genom. 2016 Aug 25;2(8) doi: 10.1099/mgen.0.000074. PMID: 28348869; PMCID: PMC5320593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.https://github.com/tseemann/snp-dists
- 11.Price M.N., Dehal P.S., Arkin A.P. FastTree 2 - Approximately maximum-likelihood trees for large alignments. PLoS One. 2010 doi: 10.1371/journal.pone.0009490. Published online. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., Järvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004 Jan 1;38(1):62–69. doi: 10.1086/380455. Epub 2003 Dec 4. PMID: 14679449. [DOI] [PubMed] [Google Scholar]
- 13.Doron S., Snydman D.R. Risk and safety of probiotics. Clin Infect Dis. 2015 doi: 10.1093/cid/civ085. Published online. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Meini S., Laureano R., Fani L., Tascini C., Galano A., Antonelli A., Rossolini G.M. Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. Infection. 2015 Dec;43(6):777–781. doi: 10.1007/s15010-015-0798-2. Epub 2015 May 30. PMID: 26024568. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

